| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||
Net income | ||||||
1,771 | 592 | |||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||
Deferred tax liabilities | ||||||
128 | - | |||||
Interest earned on investments and marketable securities held in Trust Account | ||||||
-3,473 | -1,687 | |||||
Changes in operating assets and liabilities: | ||||||
Prepaid expenses | ||||||
260 | 43 | |||||
Accounts payable | ||||||
13 | 14 | |||||
Accrued expenses | ||||||
24 | -7 | |||||
Franchise tax payable | ||||||
160 | -200 | |||||
Net cash used in operating activities | ||||||
-1,957 | -931 | |||||
Cash Flows from Investing Activities | ||||||
Principal deposited in Trust Account | ||||||
- | 158,355 | |||||
Interest released from Trust Account | ||||||
-1,171 | -324 | |||||
Net cash provided by investing activities | ||||||
1,171 | -158,030 | |||||
Cash Flows from Financing Activities: | ||||||
Proceeds from note payable to related parties | ||||||
750 | 260 | |||||
Repayment of note payable to related parties | ||||||
- | 460 | |||||
Proceeds received from initial public offering | ||||||
- | 155,250 | |||||
Offering costs | ||||||
- | 3,671 | |||||
Proceeds received from private placement | ||||||
- | 7,760 | |||||
Net cash provided by financing activities | ||||||
750 | 159,138 | |||||
Net increase in cash and cash equivalents | ||||||
-35 | 177 | |||||
Supplemental disclosure of noncash investing and financing activities: | ||||||
Offering costs included in accounts payable | ||||||
- | 67 | |||||
Deferred underwriting commissions in connection with the initial public offering | ||||||
- | 5,433 | |||||
Reclassification of deferred offering costs to paid-in capital | ||||||
- | 178 | |||||
Change in value of Class A common stock subject to possible redemption | ||||||
1,771 | 149,209 | |||||
Supplemental cash flow disclosure: | ||||||
Cash paid for income taxes | ||||||
811 | - | |||||